Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Deckert

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Der Nervenarzt|February 1, 2018
[Pharmacogenetics in psychiatry: state of the art]D J Müller, E J Brandl, F Degenhardt, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|February 13, 2018
Corrigendum to "LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease" [BBAPAP 1865 (6) (2017) 703-714]A Schrötter, A Oberhaus, K Kolbe, et al.
Psychological Medicine|December 9, 2014
Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fearsI Drenckhan, A Glöckner-Rist, F Rist, et al.
Behavioural Brain Research|August 30, 2020
BNST and amygdala activation to threat: Effects of temporal predictability and threat modeN Siminski, S Böhme, J B M Zeller, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 31, 2009
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobiaA T Gloster, H U Wittchen, F Einsle, et al.
Translational Psychiatry|April 6, 2016
MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapyC Ziegler, J Richter, M Mahr, et al.
Translational Psychiatry|December 17, 2014
The functional -1019C/G HTR1A polymorphism and mechanisms of fearB Straube, A Reif, J Richter, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 28, 2003
Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorderP Sand, K P Lesch, M Catalano, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 30, 2003
Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorderK Domschke, G Kuhlenbäumer, A Schirmacher, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Der Nervenarzt|February 1, 2018
[Pharmacogenetics in psychiatry: state of the art]D J Müller, E J Brandl, F Degenhardt, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|February 13, 2018
Corrigendum to "LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease" [BBAPAP 1865 (6) (2017) 703-714]A Schrötter, A Oberhaus, K Kolbe, et al.
Psychological Medicine|December 9, 2014
Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fearsI Drenckhan, A Glöckner-Rist, F Rist, et al.
Behavioural Brain Research|August 30, 2020
BNST and amygdala activation to threat: Effects of temporal predictability and threat modeN Siminski, S Böhme, J B M Zeller, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 31, 2009
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobiaA T Gloster, H U Wittchen, F Einsle, et al.
Translational Psychiatry|April 6, 2016
MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapyC Ziegler, J Richter, M Mahr, et al.
Translational Psychiatry|December 17, 2014
The functional -1019C/G HTR1A polymorphism and mechanisms of fearB Straube, A Reif, J Richter, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 28, 2003
Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorderP Sand, K P Lesch, M Catalano, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 30, 2003
Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorderK Domschke, G Kuhlenbäumer, A Schirmacher, et al.
Pageof 15